Literature DB >> 6025262

The reduction of folate and of dihydrofolate by homogenates of leukocytes from patients with leukemia or with myeloid metaplasia.

D Roberts, T C Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025262

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors.

Authors:  S Subramani; R Mulligan; P Berg
Journal:  Mol Cell Biol       Date:  1981-09       Impact factor: 4.272

Review 2.  An epigenetic perspective on the free radical theory of development.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

3.  Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.

Authors:  S P Rothenberg; M P Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

Review 4.  Metabolic defects provide a spark for the epigenetic switch in cancer.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

5.  Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates.

Authors:  W M Hryniuk; J R Bertino
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.